NCT01860417View on ClinicalTrials.gov

Treatment of Degenerative Disc Disease With Allogenic Mesenchymal Stem Cells (MSV)

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

June 21, 2013

Primary Completion Date

December 15, 2015

Study Completion Date

December 15, 2015

Conditions
Degenerative Disc DiseaseIntervertebral Disc DiseaseLow Back Pain
Interventions
BIOLOGICAL

Allogenic Mesenchymal Stromal Cells

DRUG

Mepivacaine

Trial Locations (2)

47003

Hospital Clinico Universitario, Valladolid

Instituto de Biologia y Genetica Molecular, Valladolid

All Listed Sponsors
collaborator

Citospin

INDUSTRY

collaborator

University of Valladolid

OTHER

lead

Red de Terapia Celular

INDUSTRY

NCT01860417 - Treatment of Degenerative Disc Disease With Allogenic Mesenchymal Stem Cells (MSV) | Biotech Hunter | Biotech Hunter